Clinical Trial Update: Bioequivalence Trial of Pyronaridine Artesunate To-be-marketed Tablet to the Clinical Trial Reference Tablet [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence trial comparing pyronaridine artesunate to the reference tablet for a to-be-marketed formulation; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Pyronaridine-artesunate (pyronaridine/artesunate)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2023-02-03